P

Pulike Biological Engineering Inc
SSE:603566

Watchlist Manager
Pulike Biological Engineering Inc
SSE:603566
Watchlist
Price: 12.43 CNY -0.56%
Market Cap: 4.3B CNY

Pulike Biological Engineering Inc
Total Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Pulike Biological Engineering Inc
Total Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
P
Pulike Biological Engineering Inc
SSE:603566
Total Liabilities
ÂĄ513m
CAGR 3-Years
0%
CAGR 5-Years
15%
CAGR 10-Years
12%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Total Liabilities
ÂĄ4B
CAGR 3-Years
-20%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Total Liabilities
ÂĄ3B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
14%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Total Liabilities
ÂĄ8.8B
CAGR 3-Years
37%
CAGR 5-Years
16%
CAGR 10-Years
20%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Total Liabilities
ÂĄ14.1B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
9%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Total Liabilities
ÂĄ3.3B
CAGR 3-Years
74%
CAGR 5-Years
37%
CAGR 10-Years
N/A
No Stocks Found

Pulike Biological Engineering Inc
Glance View

Market Cap
4.3B CNY
Industry
Pharmaceuticals

Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. The company is headquartered in Luoyang, Henan and currently employs 1,809 full-time employees. The company went IPO on 2015-05-18. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The firm's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.

Intrinsic Value
17.38 CNY
Undervaluation 28%
Intrinsic Value
Price
P

See Also

What is Pulike Biological Engineering Inc's Total Liabilities?
Total Liabilities
513m CNY

Based on the financial report for Sep 30, 2025, Pulike Biological Engineering Inc's Total Liabilities amounts to 513m CNY.

What is Pulike Biological Engineering Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
12%

Over the last year, the Total Liabilities growth was 13%.

Back to Top